Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug–drug interaction

被引:0
|
作者
Marta Koršić
Davorka Muršić
Sonja Badovinac
Nada Božina
Mihovil Roglić
Marko Jakopović
Branka Čučević
机构
[1] University Hospital Centre Zagreb,Clinic for Lung Diseases Jordanovac
[2] University Hospital Centre Zagreb,Clinical Institute of Laboratory Diagnosis
来源
关键词
Imatinib; Erlotinib; Oxycodone; Creatine Kinase Level; Serum Creatine Kinase;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1317 / 1319
页数:2
相关论文
共 50 条
  • [21] Rhabdomyolysis precipitated by a sitagliptin-atorvastatin drug interaction
    Bhome, R.
    Penn, H.
    DIABETIC MEDICINE, 2012, 29 (05) : 693 - 694
  • [24] Severe rhabdomyolysis induced by possible drug-drug interaction between Ribociclib and Simvastatin
    Streicher, Caroline
    Daulange, Annick
    Madranges, Nicolas
    Vayre, Laure
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 722 - 726
  • [25] RHABDOMYOLYSIS INDUCED BY THE CIPROFIBRATE-MICONAZOLE COMBINATION - A NEW DRUG-DRUG INTERACTION
    CLEAU, D
    HUMBLOT, S
    JOBARD, JM
    DELACOUR, JL
    FLORIOT, C
    WAGSCHAL, G
    DAOUDAL, P
    ORY, JP
    SEMAINE DES HOPITAUX, 1995, 71 (31-32): : 966 - 968
  • [26] Defining the clinical role of pharmacogenetics in antiepileptic drug therapy
    D J Dlugos
    R J Buono
    T N Ferraro
    The Pharmacogenomics Journal, 2006, 6 : 357 - 359
  • [27] Defining the clinical role of pharmacogenetics in antiepileptic drug therapy
    Dlugos, D. J.
    Buono, R. J.
    Ferraro, T. N.
    PHARMACOGENOMICS JOURNAL, 2006, 6 (06): : 357 - 359
  • [28] Pharmacogenetics of Drug Transporters
    Franke, R. M.
    Gardner, E. R.
    Sparreboom, A.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (02) : 220 - 230
  • [29] Pharmacogenetics of drug transporters
    Danesi, R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 14 - 14
  • [30] Antiepileptic drug pharmacogenetics
    Patsalos, PN
    THERAPEUTIC DRUG MONITORING, 2000, 22 (01) : 127 - 130